GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Organon & OGN · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.85

-0.14%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$6.22bn

FY2017FY2025

Net income

$187.0m

FY2017FY2025

Free cash flow

$538.0m

FY2017FY2025

Shareholders' equity

$752.0m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$6.22bn$6.40bn$6.26bn$6.17bn$6.30bn$6.53bn$7.78bn$9.78bn$10.50bn
Gross profit$3.36bn$3.71bn$3.75bn$3.88bn$3.92bn$4.41bn$5.50bn$5.08bn$5.91bn
Research and development$366.0m$469.0m$528.0m$471.0m$443.0m$210.0m$220.0m$365.0m$355.0m
Operating income$929.0m$1.33bn$1.20bn$1.71bn$1.92bn$2.85bn$3.85bn$2.71bn$3.27bn
Net income$187.0m$864.0m$1.02bn$917.0m$1.35bn$2.16bn$3.22bn$2.15bn$1.80bn
Diluted earnings per share0.723.323.993.595.318.5312.678.517.11

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$12.87bn$13.10bn$12.06bn$10.96bn$10.68bn$10.11bn$10.55bn$10.49bn—
Cash and short-term investments$574.0m$675.0m$693.0m$706.0m$737.0m$12.0m$319.0m$244.0m—
Total liabilities$12.12bn$12.63bn$12.13bn$11.85bn$12.19bn$4.62bn$3.51bn$4.15bn—
Debt$8.68bn$8.88bn$8.76bn$8.91bn$9.13bn$1.34bn$70.0m$34.0m—
Shareholders' equity$752.0m$472.0m−$70.0m−$892.0m−$1.51bn$5.49bn$7.04bn$6.35bn—
Shares outstanding260m260m257m255m255m253m254m253m253m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$700.0m$939.0m$799.0m$858.0m$2.46bn$2.19bn$2.77bn$3.69bn$3.42bn
Capital spending−$162.0m−$351.0m−$261.0m−$427.0m−$488.0m−$278.0m−$92.0m−$101.0m−$86.0m
Free cash flow$538.0m$588.0m$538.0m$431.0m$1.97bn$1.91bn$2.67bn$3.59bn$3.33bn
Dividends paid−$88.0m−$297.0m−$294.0m−$290.0m−$145.0m−$145.0m−$145.0m−$145.0m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$1.56bn$1.46bn$1.51bn$1.60bn$1.59bn$1.51bn$1.59bn$1.58bn
Gross profit$847.0m$783.0m$759.0m$857.0m$874.0m$841.0m$896.0m$923.0m
Operating income$323.0m$266.0m$235.0m$358.0m$326.0m$325.0m$296.0m$390.0m
Net income$108.0m$146.0m−$205.0m$160.0m$145.0m$87.0m$109.0m$359.0m
Diluted earnings per share0.400.54-0.790.610.560.330.421.38
Cash from operations$107.0m$225.0m$141.0m$264.0m$220.0m$75.0m$390.0m$141.0m
Capital spending−$42.0m−$37.0m−$45.0m−$115.0m−$39.0m−$97.0m−$132.0m−$76.0m
Free cash flow$65.0m$188.0m$96.0m$149.0m$181.0m−$22.0m$258.0m$65.0m
Total assets$13.18bn$13.00bn$12.87bn$13.55bn$13.50bn$13.16bn$13.10bn$12.75bn
Cash and short-term investments$1.13bn$1.12bn$574.0m$672.0m$599.0m$547.0m$675.0m$763.0m
Debt$8.55bn$8.57bn$8.68bn$8.83bn$8.90bn$8.96bn$8.92bn$8.75bn
Shareholders' equity$1.01bn$903.0m$752.0m$906.0m$733.0m$542.0m$472.0m$493.0m

Financial ratios

Data as of 30 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin54.1%58.0%59.8%62.8%62.2%67.6%
Operating margin14.9%20.7%19.2%25.0%28.3%43.6%
Net margin3.0%13.5%16.3%14.9%21.4%33.1%
Return on equity24.9%183.1%-1461.4%-102.8%-89.6%39.4%
Return on assets1.5%6.6%8.5%8.4%12.6%21.4%
Free cash flow yield24.0%35.9%29.9%36.4%83.8%70.5%
Revenue growth-2.9%2.2%1.4%-2.1%-3.5%-16.0%
Earnings growth-78.4%-15.5%11.6%-32.1%-37.5%-32.9%
Current ratio1.82x1.60x1.54x1.56x1.45x1.33x
Debt to equity11.55x18.91x-125.80x-10.05x-6.09x0.00x
Equity ratio5.8%3.6%-0.6%-8.1%-14.1%54.3%
Interest coverage1.84x2.55x2.28x3.66x6.93x474.50x
R&D as a share of sales5.9%7.3%8.4%7.6%7.0%3.2%
Buybacks as a share of market value-0.1%-1.3%-0.5%-0.3%-0.6%0.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.2%-1.0%—
Operating income-18.3%-20.1%—
Net income-41.1%-38.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin56.1%58.7%60.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings10.04.53.67.85.7
Price to sales0.30.60.61.21.2

Market value over time

28 May 2021 to 29 Oct 2026, in USD

$9.08bn$3.73bn

Share price return

Finished calendar years

20252024202320222021
Return-53%7%-51%-7%-12%

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 14 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021
Paid in the year0.060.341.121.121.120.56

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.